BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19646557)

  • 1. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.
    Delbeke D; Schöder H; Martin WH; Wahl RL
    Semin Nucl Med; 2009 Sep; 39(5):308-40. PubMed ID: 19646557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging.
    Even-Sapir E; Keidar Z; Bar-Shalom R
    Semin Nucl Med; 2009 Jul; 39(4):264-75. PubMed ID: 19497403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
    Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
    Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging.
    Brandon D; Alazraki A; Halkar RK; Alazraki NP
    Semin Oncol; 2011 Feb; 38(1):87-108. PubMed ID: 21362518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis.
    Ingui CJ; Shah NP; Oates ME
    J Comput Assist Tomogr; 2007; 31(3):375-80. PubMed ID: 17538282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    Br J Radiol; 2009 Oct; 82(982):860-76. PubMed ID: 19433487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined imaging modalities: PET/CT and SPECT/CT.
    Maurer AH
    Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
    Wong KK; Cahill JM; Frey KA; Avram AM
    Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
    Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
    Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
    Schillaci O
    Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.